LUPIN vs NGLFINE: Stock Comparison

Lupin Limited vs NGL Fine-Chem Limited

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Lupin Limited is the larger company by market capitalisation. Lupin Limited shows a lower P/E, a higher ROE and a higher dividend yield, while NGL Fine-Chem Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Lupin Limited and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LUPIN is more favourable on 9 of 13 scored metrics and NGLFINE on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
LUPIN is the larger company
₹1.1 L Cr vs ₹2,015 Cr
P/E Ratio
LUPIN has a lower P/E
21.56x vs 41.23x
P/B Ratio
LUPIN has a lower P/B
5.12x vs 6.03x
EPS
LUPIN has higher earnings per share
₹116.56 vs ₹78.04
Dividend Yield
LUPIN has a higher dividend yield
0.48% vs 0.05%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 31.9%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 89%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs 31.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLUPINNGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLUPINNGLFINE
Live Price₹2,407.5₹3,260
Day Change-4.27%0.7%
Volume10.67 L5,595
52-Week High₹2,529.5₹3,329
52-Week Low₹1,836.8₹1,175.5
Distance from 52W High-4.82%-2.07%

Valuation

MetricLUPINNGLFINE
Market Cap₹1.1 L Cr₹2,015 Cr
P/E Ratio21.56x41.23x
P/B Ratio5.12x6.03x
EPS₹116.56₹78.04
Book Value₹491.29₹532.95
Dividend Yield0.48%0.05%

Growth

MetricLUPINNGLFINE
Revenue Growth (TTM YoY)31.9%57.2%
EPS Growth (TTM YoY)89%1,539.8%
Qtr Sales Growth31.9%57.1%
Qtr Profit Growth101%2,398%

Profitability & Leverage

MetricLUPINNGLFINE
ROE29.1%15.7%
ROCE30.3%17%
Net Margin17.65%9.59%
Operating Margin31.5%14.5%
Debt to Equity0.29x0.33x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricLUPINNGLFINE
Promoter Holding46.57% 0.04 pp72.74%
FII Holding21.71% 0.22 pp0.03% 0.03 pp
DII Holding25.32% 0.26 pp0%
Public Holding6.11% 0.08 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Lupin Limited and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.